| BIOAGE LABS INC. O.N. |
| USA |
| Gesundheit |
| US09077V1008 / A40D7P |
| Y7G (Frankfurt) / BIOA (NASDAQ) |
| FRA:Y7G, ETR:Y7G, Y7G:GR, NASDAQ:BIOA |
| - |
| https://bioagelabs.com/ |
|
BioAge Labs, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for metabolic diseases by targeting the biology of human aging. BioAge Labs, Inc. advances a pipeline of product candidates designed to address conditions..
>Volltext.. |
| 318.33 Mio. EUR |
| 41.53 Mio. EUR |
| 9.1 Mio. EUR |
| -93.2 Mio. EUR |
| -83.04 Mio. EUR |
| -2.1 EUR |
| 2.49 Mio. EUR |
| 65.02 Mio. EUR |
| -77.01 Mio. EUR |
| 16.59 |
| 176.49% |
| -23.29% |
| - |
| - |
| - |
| - |
| BIOAGE LABS |
| 25.09.26 |
|
||||
|
||||
|
||||
|